Dr. Owen C. Thomas, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 18947 John J Williams Hwy Unit 101, Rehoboth Beach, DE 19971 Phone: 302-645-3775 Fax: 302-645-3774 |
Dr. Andrejs V Strauss, M.D. Radiology - Radiation Oncology Medicare: Not Enrolled in Medicare Practice Location: 18947 John J Williams Hwy, Tunnell Cancer Center, Rehoboth Beach, DE 19971 Phone: 302-645-3775 Fax: 302-645-3774 |
Samuel D Swisher-mcclure, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 18947 John J Williams Hwy Unit 101, Rehoboth Beach, DE 19971 Phone: 302-645-3775 Fax: 302-645-3774 |
Dr. Jennifer Hung, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 18947 John J Williams Hwy Unit 101, Rehoboth Beach, DE 19971 Phone: 302-645-3775 Fax: 302-645-3774 |
Dr. Brian J. Costleigh, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 18947 John J Williams Hwy, Tunnell Cancer Center, Rehoboth Beach, DE 19971 Phone: 302-645-3775 Fax: 302-645-3774 |
News Archive
Vice President Joe Biden and Health and Human Services (HHS) Secretary Kathleen Sebelius today hosted a town hall meeting with seniors in Silver Spring, Md., and released a new report, Health Insurance Reform and Medicare: Making Medicare Stronger for America's Seniors.
Doctors have long debated over the optimal time to deliver mothers with pre-eclampsia in late pregnancy (after 34 but before 37 completed weeks). This is because too early delivery compromises the baby's health, while delayed action may endanger the mother's health.
Marilyn Tavenner, acting administrator and chief operating officer of the Centers for Medicare & Medicaid Services and Caya Lewis, chief of staff at the Centers for Medicare & Medicaid Services will take part in a Web chat Wednesday, May 26, to discuss how America's Medicare recipients will benefit from the Affordable Care Act and discuss how it will reduce costs and give people more control over their health insurance.
Probactive Biotech, Inc., a Garden Grove, California-based corporation, has entered into an agreement with Dalat Nuclear Research Institute to co-develop a number of cancer drugs, utilizing combinations of antitumor antibodies and antitumor radioactive compounds. Antitumor antibodies have the ability to take antitumor compounds directly to the tumor sites within the body.
When a foreign object such as a catheter enters the body, bacteria may not only invade it but also organize into a slick coating - a biofilm - that is highly resistant to antibiotics. Like sophisticated organized crime rings, biofilms cannot be defeated by a basic approach of conventional means. Instead doctors and drug developers need sophisticated new intelligence that reveals the key players in the network and how they operate. New research led by biologists at Brown University provides exactly that dossier on some key proteins in the iconic bacterium E. coli.
› Verified 1 days ago